NCT02244320View on ClinicalTrials.gov

Observational Study in Patients With Functional Benign Prostatic Hyperplasia Symptoms Who Switched From Phytotherapy to ALNA® (Tamsulosin)

CompletedOBSERVATIONAL
Enrollment

4,150

Participants

Timeline

Start Date

September 30, 2002

Primary Completion Date

May 31, 2003

Conditions
Prostatic Hyperplasia
Interventions
DRUG

Tamsulosin

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02244320 - Observational Study in Patients With Functional Benign Prostatic Hyperplasia Symptoms Who Switched From Phytotherapy to ALNA® (Tamsulosin) | Biotech Hunter | Biotech Hunter